Literature DB >> 18172009

Regulation of MDMX expression by mitogenic signaling.

Daniele M Gilkes1, Yu Pan, Domenico Coppola, Timothy Yeatman, Gary W Reuther, Jiandong Chen.   

Abstract

MDMX is an important regulator of p53 transcriptional activity and stress response. MDMX overexpression and gene amplification are implicated in p53 inactivation and tumor development. Unlike MDM2, MDMX is not inducible by p53, and little is known about its regulation at the transcriptional level. We found that MDMX levels in tumor cell lines closely correlate with promoter activity and mRNA level. Activated K-Ras and insulin-like growth factor 1 induce MDMX expression at the transcriptional level through mechanisms that involve the mitogen-activated protein kinase and c-Ets-1 transcription factors. Pharmacological inhibition of MEK results in down-regulation of MDMX in tumor cell lines. MDMX overexpression was detected in approximately 50% of human colon tumors and showed strong correlation with increased extracellular signal-regulated kinase phosphorylation. Therefore, MDMX expression is regulated by mitogenic signaling pathways. This mechanism may protect normal proliferating cells from p53 but also hamper p53 response during tumor development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172009      PMCID: PMC2268405          DOI: 10.1128/MCB.01633-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms.

Authors:  Changgong Li; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

2.  Regulation of HDM2 activity by the ribosomal protein L11.

Authors:  Marion A E Lohrum; Robert L Ludwig; Michael H G Kubbutat; Mary Hanlon; Karen H Vousden
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

3.  ATM: ready, set, go.

Authors:  Yosef Shiloh
Journal:  Cell Cycle       Date:  2003 Mar-Apr       Impact factor: 4.534

4.  MDM2 promotes ubiquitination and degradation of MDMX.

Authors:  Yu Pan; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

5.  Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.

Authors:  Domenico Migliorini; Eros Lazzerini Denchi; Davide Danovi; Aart Jochemsen; Manuela Capillo; Alberto Gobbi; Kristian Helin; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

6.  Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity.

Authors:  Davide Danovi; Erik Meulmeester; Diego Pasini; Domenico Migliorini; Maria Capra; Ruth Frenk; Petra de Graaf; Sarah Francoz; Patrizia Gasparini; Alberto Gobbi; Kristian Helin; Pier Giuseppe Pelicci; Aart G Jochemsen; Jean-Christophe Marine
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

Authors:  Laëtitia K Linares; Arnd Hengstermann; Aaron Ciechanover; Stefan Müller; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

8.  Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter.

Authors:  Cuili Zhang; Mary M Kavurma; Angela Lai; Levon M Khachigian
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

9.  Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.

Authors:  Krishna P Bhat; Koji Itahana; Aiwen Jin; Yanping Zhang
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

10.  Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Authors:  Yanping Zhang; Gabrielle White Wolf; Krishna Bhat; Aiwen Jin; Theresa Allio; William A Burkhart; Yue Xiong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more
  35 in total

1.  Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

Authors:  Lan Wang; Guifen He; Pingzhao Zhang; Xiang Wang; Mei Jiang; Long Yu
Journal:  Mol Biol Rep       Date:  2010-03-24       Impact factor: 2.316

2.  A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.

Authors:  Hongbo Wang; Xujun Ma; Shumei Ren; John K Buolamwini; Chunhong Yan
Journal:  Mol Cancer Ther       Date:  2010-11-12       Impact factor: 6.261

Review 3.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

4.  MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination.

Authors:  Xinjiang Wang; Junru Wang; Xuejun Jiang
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

5.  MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

Authors:  Anna de Polo; Varunika Vivekanandan; John B Little; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

6.  p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors.

Authors:  Baozong Li; Qian Cheng; Zhenyu Li; Jiandong Chen
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

7.  Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE.

Authors:  Casimiro Gerarduzzi; Anna de Polo; Xue-Song Liu; Manale El Kharbili; John B Little; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

Review 8.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 9.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  MDM2 and MDMX: Alone and together in regulation of p53.

Authors:  Miriam Shadfan; Vanessa Lopez-Pajares; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2012-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.